Alvar Agusti, MD, PhD: key facts
- Kind of voice
- Academic
- Role
- MD, PhD, chair of the GOLD Board of Directors
- Quoted on
- Respiratory (asthma/COPD)
- Tracked press citations
- 5
- Most recently quoted
- 30 Sept 2026
“Discusses which COPD diagnostic bottleneck AI is closest to solving”
What Alvar Agusti, MD, PhD has said
“Using AI for COPD Diagnosis, Equity, Guideline Gaps”
MD, PhD, chair of the GOLD Board of Directors · Respiratory (asthma/COPD) · 30 Sept 2026 · Positioning New Agents and Overcoming Real-World Barriers for Asthma and COPD ↗
“Using AI for COPD Diagnosis, Equity, Guideline Gaps”
Chair of the GOLD Board of Directors · Respiratory (asthma/COPD) · 30 Sept 2026 · Asthma and COPD Biologics: What Academic Pulmonologists See in Practice ↗
“Agusti, chair of the GOLD Board of Directors, discusses which COPD diagnostic bottleneck AI is closest to solving and more.”
Chair of the GOLD Board of Directors · Respiratory (asthma/COPD) · 29 Sept 2026 · Dupilumab Cuts COPD Exacerbations Across Seasons, Smoking Status: Surya Bhatt, MD ↗
“Agusti, chair of the GOLD Board of Directors, discusses which COPD diagnostic bottleneck AI is closest to solving and more.”
Chair of the GOLD Board of Directors · Respiratory (asthma/COPD) · 28 Sept 2026 · Mepolizumab Cuts COPD Exacerbations Across Smoking Status: Claus Vogelmeier, MD ↗
Where Alvar Agusti, MD, PhD has been quoted
- Prospecting the IL-33 Pathway for COPD Care, with Nicola Hanania, MD, MShcplive.com · 30 Sept 2026
- Positioning New Agents and Overcoming Real-World Barriers for Asthma and COPDhcplive.com · 30 Sept 2026
- Asthma and COPD Biologics: What Academic Pulmonologists See in Practicehcplive.com · 30 Sept 2026
- Dupilumab Cuts COPD Exacerbations Across Seasons, Smoking Status: Surya Bhatt, MDhcplive.com · 29 Sept 2026
- Mepolizumab Cuts COPD Exacerbations Across Smoking Status: Claus Vogelmeier, MDhcplive.com · 28 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.